查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1916933

噬菌體DNA分離試劑盒市場：依萃取方法、試劑盒規格、應用和最終用戶分類－2026-2032年全球預測

Phage DNA Isolation Kit Market by Extraction Method, Kit Format, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年噬菌體 DNA 分離試劑盒市值為 1.6901 億美元，預計到 2026 年將成長至 1.9226 億美元，年複合成長率為 12.43%，到 2032 年將達到 3.8386 億美元。

關鍵市場統計數據
基準年 2025 1.6901億美元
預計年份：2026年 1.9226億美元
預測年份 2032 3.8386億美元
複合年成長率 (%) 12.43%

簡潔而有力地介紹了噬菌體 DNA 分離試劑盒在診斷、環境檢測和研究中的策略重要性。

噬菌體相關應用的興起，使得可靠的噬菌體DNA分離工具在診斷、環境檢測和實驗室中的重要性日益凸顯。本執行摘要全面概述了影響噬菌體DNA分離試劑盒普及的技術、監管和商業性趨勢，並重點闡述了其對參與檢測方法開發、監測項目以及治療藥物研發的相關人員的實際意義。

技術融合、不斷演進的工作流程以及以噬菌體為中心的應用日益增多，正在重塑供應商的優先事項和實驗室的籌資策略。

噬菌體DNA分離領域正經歷變革性的轉變，這主要得益於技術創新、實驗室工作流程的演進以及各領域對高精度核酸輸入的需求。自動化磁珠化學和新一代耗材技術的進步實現了高通量和更少的操作時間，從而促進了臨床診斷實驗室對結果可重複性和監管可追溯性的要求。同時，手動矽膠膜分離技術的改進仍然具有重要意義，它為學術機構和小規模受託研究機構提供了一種經濟高效且易於使用的解決方案。

評估 2025 年美國對噬菌體 DNA 分離試劑盒的採購和製造徵收關稅對營運和供應鏈的累積影響。

美國2025年實施的關稅對與噬菌體DNA分離試劑盒相關的供應鏈經濟、採購決策和供應商策略產生了累積影響。關稅帶來的成本壓力增加，促使企業更加重視區域採購和關鍵試劑的在地化生產，從而重新評估製造地和進口依賴程度。在評估採購韌性時，許多企業優先考慮與擁有地域分散的製造地和完善庫存管理的供應商合作，以降低其受國際關稅波動的影響。

策略性細分分析揭示了應用需求、最終用戶優先順序、萃取技術和試劑盒形式如何影響採購和開發選擇。

深入的細分分析揭示了應用、最終用戶、萃取方法和試劑盒形式如何影響噬菌體DNA分離領域的產品需求和購買行為。按應用評估，臨床診斷優先考慮感染疾病診斷和病原體檢測工作流程，這些流程需要嚴格的檢驗、完整的監管鏈文件以及與高通量自動化系統的整合。環境監測應用，例如食品安全、土壤分析和水質檢測，重視基質適應性和抗抑制劑化學，以確保噬菌體DNA在異質樣本中保持高品質。研究型應用，例如基因組學、噬菌體療法開發和疫苗開發，重視柔軟性、通訊協定透明度以及與下游定序和分析平台的兼容性。

關鍵區域洞察：闡述美洲、歐洲、中東和非洲以及亞太市場在採購因素和供應商策略上的差異

區域趨勢正清楚地影響著美洲、歐洲、中東和非洲以及亞太地區噬菌體DNA分離技術的應用模式和供應商策略。在美洲，先進的臨床實驗室和充滿活力的學術研究生態系統推動了市場需求，這些機構優先考慮自動化、檢驗的工作流程以及與定序平台的整合。某些市場的供應鏈考量和監管政策的明確性也促使製造商維護強大的本地分銷網路和服務支持，以實現快速響應。

噬菌體DNA分離市場的競爭動態、供應商差異化策略，以及供應商如何贏得信任並擴大其在不同客戶群中的規模。

噬菌體DNA分離領域的競爭格局呈現出均衡的態勢，既有成熟的生命科學供應商，也有專注於特定領域的專業廠商，還有靈活敏捷、致力於化學創新和工作流程整合的新興企業。成熟的供應商憑藉其豐富的產品系列、全球分銷網路以及跨產品協同效應，提供滿足高通量臨床和生物製藥客戶需求的端到端解決方案。這些企業往往強調檢驗的通訊協定、完善的法規支援以及確保相容性和持續耗材需求的儀器生態系統。

針對試劑盒供應商和實驗室負責人的實用策略建議：提高韌性、擴大應用範圍並加速噬菌體DNA分離工作流程的整合

產業領導者應優先採取以下切實可行的步驟，以鞏固市場地位、降低營運風險並加速噬菌體DNA分離解決方案的普及應用。首先，投資於模組化產品系列，使客戶能夠在不改變核心化學原理的情況下，從手動工作流程擴展到自動化工作流程，從而降低轉換成本並支援長期合作關係的建立。其次，擴大檢驗研究範圍，以證明該解決方案在臨床檢體（拭子）、污水、食品樣本和土壤等關鍵基質中具有一致的性能，從而增強診斷檢查室和環境檢測機構對檢測方法可靠性的信心。

為了確保研究結果的可靠性，我們採用嚴格的混合方法調查方法，結合相關人員訪談、技術評估和三角驗證的二次分析。

本分析的調查方法結合了定性和定量技術，旨在全面、深入地了解噬菌體DNA分離的現狀。關鍵數據來源包括對來自學術研究機構、生物製藥開發團隊、臨床診斷檢查室和受託研究機構（CRO）的相關人員進行深度訪談，以獲取有關工作流程限制、性能預期和採購重點的第一手資訊。此外，還對提取化學技術和試劑盒形式進行了技術評估，重點關注DNA產量、抑制劑抗性、操作時間、通量相容性和文件品質等性能指標。

簡明扼要的結論整合了技術、商業性和策略的關鍵要點，旨在指導噬菌體DNA分離領域的投資、採購和產品開發決策。

本執行摘要概述了噬菌體DNA分離技術領域的關鍵發現及其對相關相關人員的策略意義。自動化多粒子珠系統和最佳化的二氧化矽膜耗材的進步，透過提供更高通量、更佳重複性和適用於多種樣品基質的解決方案，正在重新定義實驗室的預期。從學術機構到生物製藥公司再到臨床診斷檢查室等終端用戶，都已展現出明確的優先事項，這些事項會影響試劑盒的選擇和夥伴關係重點，凸顯了客製化價值提案的重要性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依萃取方法分類的噬菌體DNA分離試劑盒市場

  • 磁珠
    • 自動化磁珠檢測
    • 手動磁珠
  • 二氧化矽膜
    • 版式
    • 旋轉柱格式

9. 噬菌體DNA分離試劑盒市場（依試劑盒類型分類）

  • 汽車套件
  • 手冊套件

第10章 噬菌體DNA分離試劑盒市場（依應用領域分類）

  • 臨床診斷
    • 感染疾病診斷
    • 病原體檢測
  • 環境監測
    • 食品安全
    • 土壤分析
    • 水質檢測
  • 研究
    • 基因組研究
    • 噬菌體療法的發展
    • 疫苗研發

第11章 噬菌體DNA分離試劑盒市場（依最終用戶分類）

  • 學術研究機構
  • 生物製藥公司
  • 臨床檢查室
  • CRO（受託研究機構）

第12章 噬菌體DNA分離試劑盒市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 噬菌體DNA分離試劑盒市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國噬菌體DNA分離試劑盒市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章美國噬菌體DNA分離試劑盒市場

第16章：中國噬菌體DNA分離試劑盒市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Bio-Rad Laboratories, Inc.
  • BioCat GmbH
  • Geneflow Ltd.
  • Hangzhou Bigfish Bio-tech Co., Ltd.
  • LubioScience AG
  • Merck KGaA
  • MP Biomedicals, LLC
  • Norgen Biotek Corp.
  • Omega Bio-tek, Inc.
  • Promega Corporation
  • QIAGEN NV
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Thomas Scientific, LLC
  • Zymo Research Corporation
Product Code: MRR-AE420CB15403

The Phage DNA Isolation Kit Market was valued at USD 169.01 million in 2025 and is projected to grow to USD 192.26 million in 2026, with a CAGR of 12.43%, reaching USD 383.86 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 169.01 million
Estimated Year [2026] USD 192.26 million
Forecast Year [2032] USD 383.86 million
CAGR (%) 12.43%

A concise, high-impact introduction that frames the strategic importance of phage DNA isolation kits across diagnostics, environmental testing, and research

The emergence of bacteriophage-focused applications has elevated the importance of reliable phage DNA isolation tools across diagnostics, environmental testing, and research laboratories. This executive summary presents an integrative view of the technological, regulatory, and commercial dynamics shaping adoption of phage DNA isolation kits, emphasizing practical implications for stakeholders engaged in assay development, surveillance programs, and therapeutic R&D.

Phage DNA isolation is increasingly recognized as a critical upstream process that directly influences downstream sequencing accuracy, qPCR sensitivity, and the quality of whole-genome assemblies. As laboratories prioritize throughput, reproducibility, and contamination control, the choice of extraction method and kit format becomes a strategic decision. Automated magnetic bead workflows offer consistency and scalability for high-volume operations, while manual spin-column or plate-based approaches continue to serve low-throughput and resource-constrained settings. These operational trade-offs have meaningful consequences for lab workflows, personnel training, and capital expenditures.

In addition to technical considerations, supply chain resilience, regulatory clarity for diagnostic use, and partnerships between kit suppliers and service laboratories are shaping procurement patterns. The following sections unpack transformative shifts, tariff-related impacts from U.S. policy changes in 2025, segmentation-driven insights, regional dynamics, competitive behaviors, actionable recommendations, and the research methodology that underpins these conclusions.

How technological convergence, workflow evolution, and rising phage-centric applications are reshaping supplier priorities and laboratory procurement strategies

The landscape for phage DNA isolation is undergoing transformative shifts driven by convergence of technological innovation, evolving laboratory workflows, and cross-sector demand for high-fidelity nucleic acid inputs. Advances in automated magnetic bead chemistry and next-generation consumable formats are enabling higher throughput with reduced hands-on time, which in turn encourages adoption in clinical diagnostic laboratories that require robust reproducibility and regulatory traceability. Concurrently, improvements in manual silica membrane formats maintain relevance by offering cost-effective, accessible solutions for academic settings and smaller contract research operations.

Moreover, the growing prominence of phage-based therapies and genomic surveillance has strengthened demand for extraction methods that preserve DNA integrity across diverse sample matrices, including environmental and clinical specimens. This has catalyzed vendor investments in extraction chemistries optimized for low-abundance phage genomes and in protocols tailored for complex matrices such as soil and wastewater. As a result, strategic partnerships between kit providers and sequencing or diagnostic service labs are becoming more common, enabling rapid validation pathways and application-specific kit adaptations.

Regulatory expectations and quality management practices are also pushing suppliers toward more transparent documentation, lot-to-lot consistency, and compatibility statements for downstream assays. These shifts collectively favor versatile platforms that balance automation, reliability, and adaptability, while also highlighting the need for vendors to demonstrate operational value beyond mere kit performance.

Assessing the cumulative operational and supply chain consequences of United States tariff measures in 2025 for phage DNA isolation kit procurement and manufacturing

U.S. tariff actions implemented in 2025 have exerted a cumulative influence on supply chain economics, sourcing decisions, and vendor strategies relevant to phage DNA isolation kits. Tariff-induced cost pressures amplified attention on regional sourcing and the localization of critical reagent production, prompting several suppliers to reassess manufacturing footprints and import dependencies. As organizations evaluated procurement resilience, many prioritized partnerships with suppliers offering diversified geographic manufacturing or robust inventory management to mitigate exposure to international tariff volatility.

In practical terms, increased landed costs for certain imported consumables incentivized laboratories and procurement teams to explore domestic alternatives or to negotiate longer-term supply agreements that included price stabilization clauses. For kit manufacturers, tariffs prompted accelerated investments in regional manufacturing capacity and in supply chain transparency to assure customers of continuity. These adjustments were particularly pronounced for high-volume clinical diagnostic laboratories and contract research organizations that depend on predictable supply schedules and cost structures.

Beyond immediate cost implications, the tariff environment stimulated broader strategic change: vendors intensified efforts to qualify local distributors, to optimize logistics and customs handling, and to redesign packaging and kit compositions to reduce cross-border tariff sensitivity. Transitioning toward localized reagent sourcing also dovetailed with quality and regulatory priorities, since regional supply chains can simplify compliance with national procurement rules and streamline documentation for clinical use. Collectively, these dynamics are fostering a more resilient, regionally attuned supply ecosystem for phage DNA isolation products.

Strategic segmentation insights revealing how application needs, end-user priorities, extraction technologies, and kit formats dictate procurement and development choices

Insightful segmentation analysis reveals how application, end user, extraction method, and kit format influence product requirements and purchasing behavior across the phage DNA isolation space. When evaluated by application, clinical diagnostics demands prioritize infectious disease diagnosis and pathogen detection workflows that require rigorous validation, chain-of-custody documentation, and integration with high-throughput automated systems. Environmental monitoring applications such as food safety, soil analysis, and water testing place a premium on matrix adaptability and inhibitors-tolerant chemistries that preserve phage DNA quality across heterogeneous samples. Research-oriented applications including genomic research, phage therapy development, and vaccine development value flexibility, protocol transparency, and compatibility with downstream sequencing and analytical platforms.

Considering end-user segments, academic research institutions often balance cost-effectiveness with methodological openness, favoring manual kits and plate formats that support iterative method development. Biopharmaceutical companies require scalable, GMP-aligned processes that integrate with internal quality systems and support regulatory dossiers for therapeutic programs. Clinical diagnostic laboratories prioritize validated automated solutions and reproducibility benchmarks, while contract research organizations emphasize turnaround time, assay robustness, and vendor responsiveness for large-scale studies.

Across extraction methods, magnetic bead technologies, available in automated and manual configurations, are increasingly chosen for their scalability and reduced contamination risk, whereas silica membrane options, offered in plate and spin column formats, remain relevant for laboratories that require straightforward, low-equipment workflows. Finally, the dichotomy of automated kits versus manual kits captures the trade-off between throughput and cost, with automation favored where volume, traceability, and reduced operator variability are imperative, and manual formats continuing to serve resource-limited or development-focused environments.

Key regional insights describing how procurement drivers and supplier strategies differ across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics are shaping adoption patterns and vendor strategies for phage DNA isolation technologies in discernible ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, demand is driven by a mix of advanced clinical laboratories and vibrant academic research ecosystems that prioritize automation, validated workflows, and integration with sequencing platforms. Supply chain considerations and regulatory clarity in certain markets also motivate manufacturers to maintain strong local distribution networks and service support for rapid turnaround.

In Europe, Middle East & Africa, diverse regulation and heterogeneous public health infrastructure influence kit choice, with significant interest in adaptable solutions that can meet both centralized clinical laboratory standards and decentralized environmental monitoring needs. Vendors operating in this region often emphasize comprehensive technical support, multilingual documentation, and validation data that align with varying national requirements. Meanwhile, in the Asia-Pacific region, rapid expansion of research capacity, growing biopharmaceutical investment, and emerging clinical diagnostic networks are fueling demand for both automated magnetic bead systems and cost-conscious manual silica membrane options. Supplier strategies here frequently include strategic partnerships, localized manufacturing, and tailored pricing models to address varied market maturity levels.

Across all regions, priorities such as supply reliability, local technical support, and clear compatibility with downstream assays are central to procurement decisions, with regional nuances informing how vendors position product portfolios and after-sales services.

Competitive dynamics and supplier differentiation strategies that define the phage DNA isolation market, highlighting how vendors secure trust and scale with diverse customer segments

Competitive behavior in the phage DNA isolation arena reflects a balanced mix of established life science suppliers, specialized niche vendors, and agile new entrants that focus on chemistry innovation or workflow integration. Established suppliers leverage broad portfolios, global distribution networks, and cross-product synergies to offer end-to-end solutions that appeal to high-throughput clinical and biopharma customers. These players often emphasize validated protocols, regulatory support, and instrument ecosystems that lock in compatibility and recurring consumable demand.

Specialized vendors differentiate through targeted extraction chemistries optimized for phage genome recovery from challenging matrices or by developing consumable formats that reduce hands-on time and contamination risk for sequencing and qPCR applications. New entrants and smaller innovators frequently concentrate on a single component of the workflow-such as magnetic bead formulations or inhibitor removal modules-enabling focused performance advantages that can be rapidly validated with collaborative research partners.

Service-oriented firms, including contract research and contract manufacturing organizations, play a pivotal role by integrating kit suppliers into end-user workflows, offering validation services, and accelerating time-to-data for customers. Across this competitive spectrum, successful vendors prioritize technical documentation, robust quality systems, and responsive customer support to build trust with clinical laboratories, biopharma developers, and academic research teams alike.

Actionable strategic recommendations for kit suppliers and laboratory leaders to strengthen resilience, expand adoption, and accelerate integration of phage DNA isolation workflows

Industry leaders should prioritize a set of pragmatic actions to strengthen market position, reduce operational risk, and accelerate adoption of phage DNA isolation solutions. First, invest in modular product portfolios that allow customers to scale from manual to automated workflows without changing core chemistries, thereby lowering switching costs and supporting long-term relationships. Second, expand validation studies that demonstrate consistent performance across key matrices-clinical swabs, wastewater, food samples, and soil-in order to reassure diagnostic labs and environmental testing providers about assay robustness.

Third, focus on supply chain resilience by qualifying multiple regional suppliers for critical reagents and by enhancing inventory transparency with customers. This strategic step mitigates the impact of cross-border trade disruptions and tariff shifts while supporting rapid order fulfillment. Fourth, deepen partnerships with sequencing providers, clinical laboratories, and contract research organizations to co-develop application-specific kits and to generate real-world validation data that shortens customer evaluation cycles. Fifth, enhance customer support capabilities, including training modules, protocol optimization services, and technical exercises that reduce adoption friction for laboratory personnel.

Finally, align product roadmaps with regulatory expectations by documenting manufacturing practices, lot-to-lot consistency, and traceability, which are particularly important for diagnostic and therapeutic development customers. Taken together, these actions will help vendors convert technological advantages into sustainable, customer-centered growth.

A rigorous, mixed-methods research methodology combining stakeholder interviews, technical assessment, and triangulated secondary analysis to ensure credible insights

The research methodology underpinning this analysis combined qualitative and quantitative techniques to produce a robust, multi-dimensional view of the phage DNA isolation landscape. Primary inputs included in-depth interviews with stakeholders across academic research institutions, biopharmaceutical development teams, clinical diagnostic laboratories, and contract research organizations to capture firsthand perspectives on workflow constraints, performance expectations, and procurement priorities. These conversations were complemented by technical assessments of extraction chemistries and kit formats, focusing on performance attributes such as DNA yield, inhibitor tolerance, hands-on time, throughput compatibility, and documentation quality.

Secondary research involved a systematic review of peer-reviewed literature, technical white papers, regulatory guidances, and publicly available product documentation to validate technical claims and to understand prevailing best practices for phage DNA handling. Competitive intelligence captured product differentiation, distribution strategies, and investment patterns without relying on proprietary datasets. Cross-validation of findings was achieved through triangulation across interview insights, technical data, and publicly disclosed vendor information.

The analytical approach emphasized segmentation by application, end user, extraction method, and kit format to ensure nuanced recommendations. Sensitivity checks addressed supply chain variables, such as regional manufacturing capacities and trade policy shifts, to identify strategic levers that suppliers and laboratory customers can use to improve resilience. Throughout, methodological rigor was maintained by documenting assumptions, interview protocols, and criteria for assessing technical performance and vendor reliability.

A succinct conclusion synthesizing technical, commercial, and strategic takeaways to guide investment, procurement, and product development decisions in the phage DNA isolation domain

This executive summary consolidates the central findings and strategic implications for stakeholders engaged with phage DNA isolation technologies. Advances in automated magnetic bead systems and optimized silica membrane consumables are redefining laboratory expectations by offering pathways to higher throughput, improved reproducibility, and adaptable solutions for diverse sample matrices. End users-ranging from academic institutions to biopharmaceutical companies and clinical diagnostic laboratories-exhibit distinct priorities that influence kit selection and partnership preferences, underscoring the importance of tailored value propositions.

Regional considerations and recent trade policy developments have prompted suppliers to increase supply chain transparency, pursue regional manufacturing options, and enhance localized technical support. Competitive dynamics reward vendors that combine chemistry performance with operational services such as validation support and training, while specialized innovators can capture niche opportunities by addressing matrix-specific extraction challenges. For laboratory leaders and procurement teams, the core takeaway is the need to evaluate extraction solutions not only on immediate performance metrics but also on factors such as scalability, regulatory alignment, and supply continuity.

Taken together, these insights provide a strategic lens for aligning product development, commercial execution, and customer engagement to accelerate adoption and to deliver reliable nucleic acid inputs for downstream phage genomic and diagnostic workflows.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Phage DNA Isolation Kit Market, by Extraction Method

  • 8.1. Magnetic Bead
    • 8.1.1. Automated Magnetic Bead
    • 8.1.2. Manual Magnetic Bead
  • 8.2. Silica Membrane
    • 8.2.1. Plate Format
    • 8.2.2. Spin Column Format

9. Phage DNA Isolation Kit Market, by Kit Format

  • 9.1. Automated Kits
  • 9.2. Manual Kits

10. Phage DNA Isolation Kit Market, by Application

  • 10.1. Clinical Diagnostics
    • 10.1.1. Infectious Disease Diagnosis
    • 10.1.2. Pathogen Detection
  • 10.2. Environmental Monitoring
    • 10.2.1. Food Safety
    • 10.2.2. Soil Analysis
    • 10.2.3. Water Testing
  • 10.3. Research
    • 10.3.1. Genomic Research
    • 10.3.2. Phage Therapy Development
    • 10.3.3. Vaccine Development

11. Phage DNA Isolation Kit Market, by End User

  • 11.1. Academic Research Institutions
  • 11.2. Biopharmaceutical Companies
  • 11.3. Clinical Diagnostic Laboratories
  • 11.4. Contract Research Organizations

12. Phage DNA Isolation Kit Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Phage DNA Isolation Kit Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Phage DNA Isolation Kit Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Phage DNA Isolation Kit Market

16. China Phage DNA Isolation Kit Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Bio-Rad Laboratories, Inc.
  • 17.6. BioCat GmbH
  • 17.7. Geneflow Ltd.
  • 17.8. Hangzhou Bigfish Bio-tech Co., Ltd.
  • 17.9. LubioScience AG
  • 17.10. Merck KGaA
  • 17.11. MP Biomedicals, LLC
  • 17.12. Norgen Biotek Corp.
  • 17.13. Omega Bio-tek, Inc.
  • 17.14. Promega Corporation
  • 17.15. QIAGEN N.V.
  • 17.16. Takara Bio Inc.
  • 17.17. Thermo Fisher Scientific Inc.
  • 17.18. Thomas Scientific, LLC
  • 17.19. Zymo Research Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHAGE DNA ISOLATION KIT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PHAGE DNA ISOLATION KIT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY AUTOMATED MAGNETIC BEAD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY AUTOMATED MAGNETIC BEAD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY AUTOMATED MAGNETIC BEAD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY MANUAL MAGNETIC BEAD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY MANUAL MAGNETIC BEAD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY MANUAL MAGNETIC BEAD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY PLATE FORMAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY PLATE FORMAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY PLATE FORMAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY SPIN COLUMN FORMAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY SPIN COLUMN FORMAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY SPIN COLUMN FORMAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY AUTOMATED KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY AUTOMATED KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY AUTOMATED KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY MANUAL KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY MANUAL KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY MANUAL KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY PATHOGEN DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY PATHOGEN DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY PATHOGEN DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY FOOD SAFETY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY FOOD SAFETY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY FOOD SAFETY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY SOIL ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY SOIL ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY SOIL ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY WATER TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY WATER TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY WATER TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY GENOMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY GENOMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY GENOMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY PHAGE THERAPY DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY PHAGE THERAPY DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY PHAGE THERAPY DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY VACCINE DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY VACCINE DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS PHAGE DNA ISOLATION KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. GCC PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GCC PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 174. GCC PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 175. GCC PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 176. GCC PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 177. GCC PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. GCC PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 179. GCC PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 180. GCC PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 181. GCC PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. G7 PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. G7 PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 204. G7 PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 205. G7 PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 206. G7 PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 207. G7 PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. G7 PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 209. G7 PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 210. G7 PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 211. G7 PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. NATO PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. NATO PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 214. NATO PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 215. NATO PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 216. NATO PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 217. NATO PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. NATO PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 219. NATO PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 220. NATO PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 221. NATO PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)